scholarly journals Application of Different Imaging Methods in the Early Diagnosis of Primary Hepatic Carcinoma

2016 ◽  
Vol 2016 ◽  
pp. 1-7 ◽  
Author(s):  
Xin’ai Wu ◽  
Jianbo Li ◽  
Cheng Wang ◽  
Guojian Zhang ◽  
Na Zheng ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Early Stage ◽  
Survival Rates ◽  
Hepatic Carcinoma ◽  
Imaging Methods ◽  
Positron Emission ◽  
Ultrasound Computed Tomography ◽  
Primary Hepatic Carcinoma ◽  
The Common ◽  
The One

Primary hepatic carcinoma (PHC) is the one of the most common tumors and the common cause of cancer death in the world. Detecting PHC in its early stage by imaging methods may greatly increase survival rates of patients. Ultrasound, computed tomography, magnetic resonance imaging, and positron emission tomography/computed tomography are common imaging methods in the diagnosis of PHC. In this paper, the application of different imaging methods in diagnosing the primary hepatic carcinoma will be discussed.

scholarly journals A Meta-Analysis of Arsenic Trioxide Combined with Transcatheter Arterial Chemoembolization for Treatment of Primary Hepatic Carcinoma

2016 ◽  
Vol 2016 ◽  
pp. 1-10 ◽  
Author(s):  
Ling He ◽  
Qingyun Xu ◽  
Liguo Chen ◽  
Ruixue Chen
Keyword(s):  
Meta Analysis ◽  
Efficacy Rate ◽  
Malignant Tumours ◽  
Hepatic Carcinoma ◽  
Randomized Controlled ◽  
Primary Hepatic Carcinoma ◽  
One Year ◽  
The One ◽  
Arterial Chemoembolization

Primary hepatic carcinoma (PHC) is one of the most common malignant tumours in the world. More and more research has shown that As2O3combined with TACE has a good curative effect in treating PHC. The objectives of this study were to evaluate the therapeutic efficacy and safety of As2O3combined with TACE in treating PHC. The CNKI, VIP, Wanfang, PubMed, and Cochrane databases were searched from their inception until December 2015. Randomized controlled trials (RCTs) comparing As2O3combined with TACE versus TACE alone in treating PHC were identified. Stata SE 12.0 was used for data analysis. 17 RCTs with 1055 patients were included. Meta-analysis showed that, compared with TACE alone, As2O3combined with TACE showed significant effects in improving the clinical efficacy rate (P<0.01), decreasing the value of alpha-fetoprotein (P<0.01), increasing the one-year survival rate (P<0.01), and improving the quality of life of PHC patients (P<0.01). Fifteen studies had mentioned adverse events, but no serious adverse effects were reported in any of the included trials. In conclusion, As2O3combined with TACE therapy appears to be potentially effective in treating PHC and is generally safe. However, further studies with rigorous designs trials and multiregional cooperation trials are needed.

Sign in / Sign up

Export Citation Format

Share Document